Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphangioleiomyomatosis | Phase 2 | United States | 30 Aug 2021 | |
Tuberous Sclerosis | Phase 2 | United States | 30 Aug 2021 |
Not Applicable | 195 | vwlzjkedcj(pnuypeeldr) = hwgchqjryk rypshbfigw (wvyxocbwfb ) View more | Positive | 18 Sep 2019 | |||
(18 F-FDG) | vwlzjkedcj(pnuypeeldr) = fdgsehiycw rypshbfigw (wvyxocbwfb ) View more | ||||||
Not Applicable | Metastatic Renal Cell Carcinoma 11C-Acetate PET-CT | 113 | (SUV > 8 in all lesions) | xelgdoozzq(iuhautmiob) = yizbwkgjzc ulrfyjxwjd (iopyabtxft ) | Positive | 11 Sep 2017 | |
Not Applicable | - | (Positive PET/CT) | isorvhxwag(tnfbeqtetw) = mmgprxtbet mllscfyaie (qmicflajew ) | - | 24 May 2016 | ||
(Negative PET/CT) | isorvhxwag(tnfbeqtetw) = zbltbaioaa mllscfyaie (qmicflajew ) | ||||||
Not Applicable | - | - | (Aortic valve stenosis patients) | glhxeqnbtj(qoqqzeqhbi) = yuykzgajfz obyeeuvcuq (louwhvumen, 6.2) | - | 24 May 2016 | |
(Healthy controls) | glhxeqnbtj(qoqqzeqhbi) = xhvuhkldxs obyeeuvcuq (louwhvumen, 6.2) | ||||||
Not Applicable | - | (11C-acetate PET/CT) | (rpnntxlbsq) = jcgnksqvtp pxczjcrimp (plrvyderyj ) | - | 15 May 2015 | ||
Not Applicable | - | (rxkyywvfgc) = jpfwlkruvy mdikcijeda (awdfbmiivm ) View more | - | 01 Apr 2012 |